146 related articles for article (PubMed ID: 12463316)
1. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions.
Furui J; Ishii M; Ikeda H; Muta H; Egami K; Sugahara Y; Himeno W; Akagi T; Kato H; Matsuishi T
Acta Paediatr; 2002; 91(11):1183-8. PubMed ID: 12463316
[TBL] [Abstract][Full Text] [Related]
2. Soluble forms of P-, E- and L-selectin in children with Kawasaki disease.
Furui J
Kurume Med J; 2001; 48(2):135-43. PubMed ID: 11501494
[TBL] [Abstract][Full Text] [Related]
3. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble selectins in Kawasaki disease.
Takeshita S; Dobashi H; Nakatani K; Koike Y; Tsujimoto H; Hirayama K; Kawamura Y; Mori K; Sekine I; Yoshioka S
Clin Exp Immunol; 1997 Jun; 108(3):446-50. PubMed ID: 9182890
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.
Schiller B; Elinder G
Acta Paediatr; 1999 Aug; 88(8):844-8. PubMed ID: 10503683
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
Chen YL; Wang JL; Li WQ
Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
[TBL] [Abstract][Full Text] [Related]
9. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
10. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
11. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
Kim HJ; Choi EH; Kil HR
J Korean Med Sci; 2014 Oct; 29(10):1385-90. PubMed ID: 25368492
[TBL] [Abstract][Full Text] [Related]
12. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825
[TBL] [Abstract][Full Text] [Related]
13. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble E-selectin levels in Kawasaki disease.
Kim DS; Lee KY
Scand J Rheumatol; 1994; 23(5):283-6. PubMed ID: 7526448
[TBL] [Abstract][Full Text] [Related]
15. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S; Zhang H; Zhang R; Tang M; Luo E; Yang Y; Gao Y; Yue S; Liang H; Cai J
J Pediatr (Rio J); 2023; 99(4):406-412. PubMed ID: 36977496
[TBL] [Abstract][Full Text] [Related]
16. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
Qi Y; Gong F; Zhang Q; Xie C; Wang W; Fu S
Arthritis Res Ther; 2012 Nov; 14(6):R251. PubMed ID: 23171632
[TBL] [Abstract][Full Text] [Related]
17. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
[TBL] [Abstract][Full Text] [Related]
18. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
[TBL] [Abstract][Full Text] [Related]
19. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.
He YE; Qiu HX; Wu RZ; Rong X; Xu HT; Xiang RL; Chu MP
J Cardiovasc Transl Res; 2020 Apr; 13(2):204-214. PubMed ID: 31428922
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
